SII To Produce 100 Million Doses Of Covishield From May

New Delhi: The Serum Institute of India (SII) has geared up to raise the output of Covishield vaccines by 67% to 100 million doses a month from May. The move comes in the backdrop of the increasing demand for vaccines in view of the fast multiplying cases of COVID in India and all over the world.

The SII has set a target to increase the output from 60 million doses to 100 million per month, the Economic Times reported. “The Serum Institute would boost manufacturing from May,” Chief executive Adar Poonawalla had told ET in an interview in January.

The Serum Institute, the world’s largest vaccine manufacturer of vaccines, did not respond to queries of ET, the publication said in its report.